Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.
2 active warrant series covering 6,311,442 shares (~5.8% potential dilution); nearest expiry 2027-04-19.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.27 | Apr 19, 2027 190d | 2.0M | OTM | 1.8% | C$533K | Auto |
| warrant | $0.27 | Dec 20, 2027 435d | 4.3M | OTM | 4.0% | C$1.2M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
6 option grants covering 11,150,000 shares (~10.2% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.10 | Jan 5, 2027 86d | 1.5M | OTM | 1.4% | C$150K | Auto |
| option | $0.10 | Jul 13, 2027 275d | 300K | OTM | 0.3% | C$30K | Auto |
| option | $0.10 | May 29, 2030 1326d | 1.2M | OTM | 1.1% | C$126K | Auto |
| option | $0.12 | Oct 3, 2030 1453d | 1.0M | OTM | 0.9% | C$120K | Auto |
| option | $0.10 | Apr 20, 2031 1652d | 4.8M | OTM | 4.4% | C$485K | Auto |
| option | $0.18 | Nov 6, 2033 2583d | 2.3M | OTM | 2.1% | C$414K | Auto |
109,236,032 shares outstanding, plus 6,311,442 from warrants and 11,150,000 from options, and 2,450,000 from restricted share units — a fully diluted 129,147,474 shares, or ~18.2% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.